ULTRAGENYX PHARMACEUTICAL INC. Warrants Not Settleable in Cash, Fair Value Disclosure
ULTRAGENYX PHARMACEUTICAL INC. (RARE) had Warrants Not Settleable in Cash, Fair Value Disclosure of $6.70 million as of 2014-01-30, per its 10-K filed 2017-02-17.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:WarrantsNotSettleableInCashFairValueDisclosure · last filed 2017-02-17
- 2014-01-30: Warrants Not Settleable in Cash, Fair Value Disclosure $6.70M.
- 2013-12-31: Warrants Not Settleable in Cash, Fair Value Disclosure $3.40M.
- 2011-06-30: Warrants Not Settleable in Cash, Fair Value Disclosure $200.00K; Warrants Not Settleable in Cash, Fair Value Disclosure as first filed $203.00K.
| Period end | Warrants Not Settleable in Cash, Fair Value Disclosure | Warrants Not Settleable in Cash, Fair Value Disclosure as first filed |
|---|---|---|
| 2014-01-30 | $6.70M 10-K · filed 2017-02-17 | |
| 2013-12-31 | $3.40M 10-K · filed 2016-02-26 | |
| 2011-06-30 | $200.00K 10-K · filed 2017-02-17 | $203.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |